The RECOVER IV Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Study Chair - Navin Kapur, MD
Tufts Medical Center
Principal Investigator - William O'Neill, MD
Henry Ford Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rigshospitalet Copenhagen
Copenhagen, Denmark
- Herzzentrum Dresden
Dresden, Saxony, Germany
- University Hospital Düsseldorf
Düsseldorf, Germany
- Universitatsklinikum Schleswig Holstein
Kiel, Germany
- Krankenhaus Der Barmherzigen Brüder Trier
Trier, Germany
- Inselspital Bern
Bern, Switzerland
- New Mexico Heart Institute
Albuquerque, New Mexico, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Oct 2023
- Primary completion
- 10 May 2024
- Completion
- 6 Dec 2024
- Last update posted
- 29 Jan 2025
- Registered enrollment
- 4
- Registry id
- NCT05506449
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.